Until May, it was a little-known biotech company. In just a few months, since it became a significant player in the hunt for a Covid-19 vaccine, Moderna has become a familiar stock to most traders across the market. Its vaccine candidate, mRNA-1273, and its CEO, Stephane Bancel are now relatively well known.
Last night, I watched my nation vote to leave the European Union. Leaving will take many years, and it will have many far-reaching and unforeseeable consequences for millions of people who have no control whatsoever over the outcomes as they unfold in the years to come. However, for some people, Brexit was a perfect smokescreen. The real story is not Brexit.